CASE Op-Ed in The Washington Times: How Congress can help pay for Trump’s agenda — while empowering consumers
As Republicans in the House and Senate search for ways to fund President Trump’s agenda in the upcoming budget reconciliation...
CASE Op-Ed – RealClear Markets: Nancy Pelosi’s Price Fixing Scheme Threatens Drug Innovation
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country,...
Hospitals Support Transparency, Except When They Have To Be Transparent
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price...
Importing Prescription Drugs: Unsafe and Unwanted
Yesterday, the U.S. Department of Health and Human Services released a proposal, outlining two pathways to allow for the importation...
CASE Op-Ed – RealClear Energy: Always Evolving Coal Technologies Key to Trump’s Climate Plan
Matthew Kandrach – President, CASE June 26, 2019 As the United States enters a long era of reducing carbon emissions,...
CASE Op-Ed – RealClear Health: Socialist Price Schemes Will Be Harmful to Patients
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that...
CASE Op-ed, InsideSources: America Deserves Quality Infrastructure
Matthew Kandrach – President CASE March 4, 2019 – https://bit.ly/2EAZi6S The Senate Commerce Committee in February took up how multiple...
The Six Protected Classes Are Protected For A Reason
We’ve been vocal about how the Trump Administration has championed patients in their efforts to lower the cost of...
CASE Op-Ed, InsideSources: Let’s Not Pollute our Waterways with Unnecessary Federal Regulation
Matthew Kandrach – President, CASE December 21, 2018 – https://bit.ly/2CtZdlp Is it possible to have cleaner waterways across the country and,...
The Problem With Price Caps: Why CMS Should Rethink Its Part B Proposal
This week, we submitted comments to Health and Human Services (HHS) Secretary Alex Azar, urging him to reevaluate and abandon...
- 1
- 2
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fd...
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!